Ikena Oncology, Inc.

NASDAQ:IKNA

1.71 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q12019 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 44.26852.852119.894121.27770.86829.32959.91967.07448.48746.877232.217245.899264.004281.01162.49155.86-82.08382.083
Short Term Investments 101.151104.49755.57175.65686.444108.48497.028107.287144.323165.498000000164.1660
Cash and Short Term Investments 145.419157.349175.465196.933157.312137.813156.947174.361192.81212.375232.217245.899264.004281.01162.49155.8682.08382.083
Net Receivables 000000000000000000
Inventory 000000000000000000
Other Current Assets 3.9023.8173.1971.0190.7311.4130.9641.1792.2961.050.6291.0280.4910.6341.5612.82203.122
Total Current Assets 149.321161.166178.662200.634160.646141.178160.01177.978199.145216.05236.516251.865268.71283.234165.96958.68282.08385.205
Non-Current Assets:
Property, Plant & Equipment, Net 5.5516.1058.02110.6267.458.0448.468.78.868.5188.9778.9689.2459.5561.5631.2100.769
Goodwill 000000000000000000
Intangible Assets 000000000000000000
Goodwill and Intangible Assets 000000000000000000
Long Term Investments 1.2781.2781.2781.2783.6683.1790.8723.793.1793.1792.3860.8720.8720.8720000
Tax Assets 000000000000000000
Other Non-Current Assets 1.3354.2334.1312.797002.91700000000.8720.872-82.0830
Total Non-Current Assets 8.16411.61613.4314.70111.11811.22312.24912.4912.03911.69711.3639.8410.11710.4282.4352.082-82.0830.769
Total Assets 157.485172.782192.092215.335171.764152.401172.259190.468211.184227.747247.879261.705278.827293.662168.40460.764085.974
Liabilities & Equity:
Current Liabilities:
Account Payables 1.4081.9092.0663.951.7722.7592.0932.3614.0922.3882.3841.9282.4742.5282.1221.05100.935
Short Term Debt 3.6953.4433.5583.4691.9371.921.9071.8941.881.8631.8511.8381.8261.5840.186000
Tax Payables 000000000000000000
Deferred Revenue 0000.6591.8443.8479.1612.10817.19416.74917.122.57422.47222.33920.622000
Other Current Liabilities 3.0934.8178.58111.1936.4555.4248.3438.6775.3484.3315.8544.2323.7713.5645.40226.626023.362
Total Current Liabilities 8.19610.16914.20519.27112.00813.9521.50325.0428.51425.33127.18930.57230.54330.01528.33227.677024.297
Non-Current Liabilities:
Long Term Debt 5.3976.3027.188.0233.0563.4293.7874.1384.4834.8165.1355.4495.7566.0530000
Deferred Revenue Non-Current 00000002.5023.8194.6457.67822.42126.26829.9535.141000
Deferred Tax Liabilities Non-Current 0000000-2.502-3.819-4.645-7.678-22.421-26.268-29.950000
Other Non-Current Liabilities 1.0330.9640.9532.6970002.5023.81900000205.979000
Total Non-Current Liabilities 6.437.2668.1340.723.0563.4293.7876.648.3029.46112.81327.8732.02436.003241.12000
Total Liabilities 14.62617.43522.33559.99115.06417.37925.2931.6836.81634.79240.00258.44262.56766.018269.45227.677024.297
Equity:
Preferred Stock 00031.8450000000261.705278.827293.662205.97978.86778.86778.867
Common Stock 0.0480.0480.0480.0440.0420.0360.0360.0360.0360.0360.0360.0360.0360.0360.0030.01900.019
Retained Earnings -312.261-298.531-282.385-262.896-245.553-228.438-214.219-200.122-182.784-162.293-145.454-148.251-133.736-121.055-111.339-85.2880-67.083
Accumulated Other Comprehensive Income/Loss -0.35-0.313-0.048-0.29-0.456-0.491-0.763-1.181-1.104-0.4780-261.705-278.827-293.662-205.979-0-61.4630
Other Total Stockholders Equity 455.422454.143452.142386.641402.667363.915361.915360.055358.22355.69353.295351.478349.96348.663-195.6916.76905.601
Total Shareholders Equity 142.859155.347169.757155.344156.7135.022146.969158.788174.368192.955207.877203.263216.26227.644-101.0480.36717.40417.404
Total Equity 142.859155.347169.757155.344156.7135.022146.969158.788174.368192.955207.877203.263216.26227.644-101.0480.36717.40417.404
Total Liabilities & Shareholders Equity 157.485172.782192.092215.335171.764152.401172.259190.468211.184227.747247.879261.705278.827293.662168.40428.04417.40441.701